Explore how U.S. Congressional actions are impacting industrial hemp businesses and the proposed marijuana rescheduling, ...
Explore the US Justice Department's reclassification of medical cannabis to Schedule III, impacting tax breaks for businesses ...
A Travis County district judge has extended a temporary injunction, allowing Texas shops to continue selling smokable hemp ...
HempToday's Kehrt Reyher discusses industrial hemp policy, CBD regulation, and market development. Insights cover legislative ...
Indiana Governor Mike Braun signals a shift in medical cannabis policy after federal rescheduling. A RAND study details ...
The US Justice Department's recent order reclassifies medical cannabis, removing it from Schedule I. This move impacts ...
The DEA has launched an online registration portal for state-licensed medical cannabis firms, providing federal recognition, ...
Explore how potential US federal medical cannabis reclassification could impact market dynamics, regulatory frameworks, and ...
The US Department of Justice's move to reclassify medical cannabis to Schedule III could unlock critical research ...
Explore how Curaleaf's full acquisition of EU-GMP licensed Four 20 Pharma solidifies its presence in the expanding German ...
A recent cannabidiol gel trial for Fragile X Syndrome did not meet its primary endpoint, largely due to a high placebo ...
Explore how federal cannabis rescheduling could activate existing South Carolina laws, potentially granting patients medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results